The study suggests that careful consideration should be exercised for autologous stem-cell rescue with CD34+ selection in NB patients due to the risk of reinfusing NB-CSCs that could lead to post-transplant relapse [67]. The gene discussed is CD34; the disease is neuroblastoma.